These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23869226)

  • 1. High weight loss during radiation treatment changes the prognosis in under-/normal weight nasopharyngeal carcinoma patients for the worse: a retrospective analysis of 2433 cases.
    Shen LJ; Chen C; Li BF; Gao J; Xia YF
    PLoS One; 2013; 8(7):e68660. PubMed ID: 23869226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overweight/obese status associates with favorable outcome in patients with metastatic nasopharyngeal carcinoma: a 10-year retrospective study.
    Li W; Shen LJ; Chen T; Sun XQ; Zhang Y; Wu M; Shu WH; Chen C; Pan CC; Xia YF; Wu PH
    Chin J Cancer; 2016 Aug; 35(1):75. PubMed ID: 27507261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A retrospective study of 606 cases of nasopharyngeal carcinoma with or without oropharyngeal candidiasis during radiotherapy.
    Qiu WZ; Ke LR; Xia WX; Yang J; Yu YH; Liang H; Huang XJ; Liu GY; Li WZ; Xiang YQ; Guo X; Lv X
    PLoS One; 2017; 12(8):e0182963. PubMed ID: 28797119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of effect of body mass index and weight loss on survival of patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy.
    Lin YH; Chang KP; Lin YS; Chang TS
    Radiat Oncol; 2015 Jun; 10():136. PubMed ID: 26122711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical weight loss predicts poor prognosis in nasopharyngeal carcinoma.
    Zeng Q; Shen LJ; Guo X; Guo XM; Qian CN; Wu PH
    BMC Cancer; 2016 Feb; 16():169. PubMed ID: 26926144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new prognostic histopathologic classification of nasopharyngeal carcinoma.
    Wang HY; Chang YL; To KF; Hwang JS; Mai HQ; Feng YF; Chang ET; Wang CP; Kam MK; Cheah SL; Lee M; Gao L; Zhang HZ; He JH; Jiang H; Ma PQ; Zhu XD; Zeng L; Chen CY; Chen G; Huang MY; Fu S; Shao Q; Han AJ; Li HG; Shao CK; Huang PY; Qian CN; Lu TX; Li JT; Ye W; Ernberg I; Ng HK; Wee JT; Zeng YX; Adami HO; Chan AT; Shao JY
    Chin J Cancer; 2016 May; 35():41. PubMed ID: 27146632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-treatment serum lactic dehydrogenase as a predictive indicator for distant metastasis and survival of patients with nasopharyngeal carcinoma.
    Wang J; Li L; Dong BQ; Xu YJ; Zheng YD; Sun ZW; Yang Y; Chen YY; Chen XZ; Chen M
    Oncotarget; 2016 May; 7(19):27458-67. PubMed ID: 27050275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Image-based Multilevel Subdivision of M1 Category in TNM Staging System for Metastatic Nasopharyngeal Carcinoma.
    Shen L; Li W; Wang S; Xie G; Zeng Q; Chen C; Shi F; Zhang Y; Wu M; Shu W; Pan C; Xia Y; Wu P
    Radiology; 2016 Sep; 280(3):805-14. PubMed ID: 27023116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of quality of life measured after treatment on subsequent survival in patients with nasopharyngeal carcinoma.
    Tsai WL; Chien CY; Huang HY; Liao KC; Fang FM
    Qual Life Res; 2013 May; 22(4):715-23. PubMed ID: 22669472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Prognostic Value of Treatment-Related Lymphopenia in Nasopharyngeal Carcinoma Patients.
    Liu LT; Chen QY; Tang LQ; Guo SS; Guo L; Mo HY; Chen MY; Zhao C; Guo X; Qian CN; Zeng MS; Bei JX; Tan J; Chen S; Hong MH; Shao JY; Sun Y; Ma J; Mai HQ
    Cancer Res Treat; 2018 Jan; 50(1):19-29. PubMed ID: 28392551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgery for isolated regional failure in nasopharyngeal carcinoma after radiation: Selective or comprehensive neck dissection.
    Liu YP; Li H; You R; Li JB; Liu XK; Yang AK; Guo X; Song M; Zhang Q; Guo ZM; Chen WK; Liu WW; Zou X; Hua YJ; Yang Q; Zhang YN; Sun R; Mo HY; Guo L; Lin AH; Mai HQ; Qian CN; Chen MY
    Laryngoscope; 2019 Feb; 129(2):387-395. PubMed ID: 30325027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment Body Mass Index (BMI) as an Independent Prognostic Factor in Nasopharyngeal Carcinoma Survival: A Systematic Review and Meta-Analysis.
    Jin X; Hu R; Guo H; Ding C; Pi G; Tian M
    Nutr Cancer; 2022; 74(10):3457-3467. PubMed ID: 35658769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasopharyngeal carcinoma in children and adolescents in an endemic area: a report of 185 cases.
    Yan Z; Xia L; Huang Y; Chen P; Jiang L; Zhang B
    Int J Pediatr Otorhinolaryngol; 2013 Sep; 77(9):1454-60. PubMed ID: 23830224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective study of the prognostic value of MRI-derived residual tumors at the end of intensity-modulated radiotherapy in 358 patients with locally-advanced nasopharyngeal carcinoma.
    He Y; Zhou Q; Shen L; Zhao Y; Lei M; Wei R; Shen L; Cao S
    Radiat Oncol; 2015 Apr; 10():89. PubMed ID: 25881159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival impact of waiting time for radical radiotherapy in nasopharyngeal carcinoma: A large institution-based cohort study from an endemic area.
    Liang H; Xiang YQ; Lv X; Xie CQ; Cao SM; Wang L; Qian CN; Yang J; Ye YF; Gan F; Ke LR; Yu YH; Liu GY; Qiu WZ; Huang XJ; Wen CH; You N; Wang XQ; Guo X; Xia WX
    Eur J Cancer; 2017 Mar; 73():48-60. PubMed ID: 28161498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective study comparing the outcomes and toxicities of intensity-modulated radiotherapy versus two-dimensional conventional radiotherapy for the treatment of children and adolescent nasopharyngeal carcinoma.
    Qiu WZ; Peng XS; Xia HQ; Huang PY; Guo X; Cao KJ
    J Cancer Res Clin Oncol; 2017 Aug; 143(8):1563-1572. PubMed ID: 28342002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Forty-six cases of nasopharyngeal carcinoma treated with 50 Gy radiotherapy plus hematoporphyrin derivative: 20 years of follow-up and outcomes from the Sun Yat-sen University Cancer Center.
    Xu BQ; Tu ZW; Tao YL; Liu ZG; Li XH; Yi W; Jiang CB; Xia YF
    Chin J Cancer; 2016 Apr; 35():37. PubMed ID: 27056488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment prognostic factors of survival and late toxicities for patients with nasopharyngeal carcinoma treated by simultaneous integrated boost intensity-modulated radiotherapy.
    Lin YH; Huang TL; Chien CY; Chen HC; Hsu HC; Huang EY; Wang CJ; Huang YJ; Wang YM; Huang CC; Chou SY; Liao KC; Fang FM
    Radiat Oncol; 2018 Mar; 13(1):45. PubMed ID: 29554940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of PD-L1 Expression of Tumor Cells with Survival Outcomes after Radical Intensity-Modulated Radiation Therapy for Non-Metastatic Nasopharyngeal Carcinoma.
    Lee VH; Lo AW; Leung CY; Shek WH; Kwong DL; Lam KO; Tong CC; Sze CK; Leung TW
    PLoS One; 2016; 11(6):e0157969. PubMed ID: 27341634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival impact of radiotherapy interruption in nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: A big-data intelligence platform-based analysis.
    Yao JJ; Zhang F; Gao TS; Zhang WJ; Lawrence WR; Zhu BT; Zhou GQ; Ma J; Wang SY; Sun Y
    Radiother Oncol; 2019 Mar; 132():178-187. PubMed ID: 30448002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.